Peter Sguigna, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Clene NanoMedicine
    Topic:
    Clinical Trial PI
    Date added:
    Date updated:
    10/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech
    Topic:
    Clinical Trial PI
    Date added:
    02/08/2022
    Date updated:
    10/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genentech
    Topic:
    Consulting Services
    Date added:
    02/08/2022
    Date updated:
    10/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Consulting Services
    Date added:
    02/08/2022
    Date updated:
    10/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Intellectual Property Other
    Ineligible company:
    VIC Tech
    Topic:
    Consulting Services
    Date added:
    02/08/2022
    Date updated:
    10/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Medscape
    Topic:
    Consulting Services
    Date added:
    02/08/2022
    Date updated:
    10/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Spherix Global Insights
    Topic:
    Consulting Services
    Date added:
    02/08/2022
    Date updated:
    10/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Guidepoint
    Topic:
    Consulting Services
    Date added:
    02/08/2022
    Date updated:
    10/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Horizon Therapeutics
    Topic:
    Consulting Services
    Date added:
    10/25/2023
    Date updated:
    10/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    EMD Serono
    Topic:
    Consulting Services
    Date added:
    10/25/2023
    Date updated:
    10/25/2023
Return to 229 OBI Grand Rounds: RNA-Targeted Therapies for Neurodegenerative Disease 05.08.24